Company Overview
- Website
- luxtherapeutics.com
- Employees
- 7
- Industry
- Hospital/Clinic
Financials & Stats
Revenue
$10B
Recent News & Media
Referral Program
- May 11, 2025
- ponyatherapeutics.com
LUX Therapeutics
- May 5, 2025
- ponyatx.tkconsultingdesign.com
Theramend, 13mm
- Feb 8, 2025
- woundreference.com
LUX Therpeutics | Empowerment Through Innovative Regenerative Medicine
- Jan 29, 2025
- luxtherapeutics.framer.website
🌟 Introducing THERAMEND™ 🌟 We’re excited to introduce THERAMEND™, our patch allograft product derived from the amniotic membrane. At LUX Therapeutics, we are committed to delivering innovative solutions that empower healthcare providers and im
- Jan 15, 2025
- linkedin.com
Centers for Medicare & Medicaid Services
- Jul 2, 2024
- cms.gov
Who is LUX Therapeutics
LUX Therapeutics is a biotechnology company based in Atlanta, Georgia. The company employs 7 people and generates over $10,000 in annual revenue. LUX Therapeutics specializes in the development and production of tissue allograft products used in regenerative medicine. Their products are intended to aid in the healing and repair of damaged tissues. The company differentiates itself through its focus on science-based, clinically established, and personalized regenerative therapies. LUX Therapeutics leverages its expertise across multiple disciplines to create innovative solutions in the field of regenerative medicine. You can learn more about LUX Therapeutics and its products by visiting their website at luxtherapeutics.com.
LUX Therapeutics Industry Tags
Companies Similar to LUX Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to LUX Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 51 | Tucson, AZ | ||
| 10M | 12 | Philadelphia, PA | ||
| 10M | 26 | Glendale, AZ | ||
| 10M | 1 | Dallas, TX | 1996 | |
| 10M | Boston, MA | 2017 |